Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Flexner

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Hematological Oncology|July 1, 1990
Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell processJ P Greer, K E Salhany, J B Cousar, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
The American Journal of Medicine|August 1, 1986
Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patientsJ P Greer, M C Kinney, J B Cousar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Hematological Oncology|July 1, 1990
Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell processJ P Greer, K E Salhany, J B Cousar, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
The American Journal of Medicine|August 1, 1986
Lymphocyte-depleted Hodgkin's disease. Clinicopathologic review of 25 patientsJ P Greer, M C Kinney, J B Cousar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcomeA F List, J P Greer, J C Cousar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
Pageof 7